$265.68 $0.04 (0.0%)

08:00 PM EDT on 07/09/20

ABIOMED, Inc. (NASDAQ:ABMD)

CAPS Rating: 5 out of 5

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

Current Price $265.68 Mkt Cap $12.0B
Open $0.00 P/E Ratio 59.13
Prev. Close $265.68 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 257,240
52-Wk Range $119.01 - $285.77 Avg. Daily Vol. 482,706

Caps

How do you think NASDAQ:ABMD will perform against the market?

Add Stock to CAPS Watchlist

All Players

342 Outperform
32 Underperform
 

All-Star Players

145 Outperform
12 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ABMD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFPencils (99.93)
Submitted August 09, 2019

Despite what appear to be shorter-term headwinds, Abiomed continues to pump out cash and maintain a sterling balance sheet. The valuation is at levels not seen much (if at all) over the past five years. The company's "issues" seem correctable to me,… More

ScreenerStizBear (55.19)
Submitted June 26, 2008

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

Recent Community Commentary

Read the most recent pitches from players about ABMD.

Recs

0
Member Avatar NapaCabernet (95.16) Submitted: 6/10/2020 11:32:00 AM : Outperform Start Price: $249.13 NASDAQ:ABMD Score: +8.26

fool pick and buy

Recs

0
Member Avatar EKO01 (69.44) Submitted: 6/7/2020 5:41:06 PM : Outperform Start Price: $237.23 NASDAQ:ABMD Score: +13.88

the well-known manufacturer of heart pumps comes from a very hard period of 18 months. after losing more than 50% from the highs, paying less sales also due to a series of responses that are not always favorable for its point product: IMPELLA. but now the green light to the adoption of IMPELLA ECP on patients who have undergone PCI. soon it is legitimate to think that it will begin a rapid ascent towards new goals.

Recs

0
Member Avatar nigelsjthomas (91.36) Submitted: 5/31/2020 4:21:52 PM : Outperform Start Price: $218.53 NASDAQ:ABMD Score: +18.10

Great CEO

Leaderboard

Find the members with the highest scoring picks in ABMD.

Score Leader

ClaytonHP

ClaytonHP (< 20) Score: +4,514.89

The Score Leader is the player with the highest score across all their picks in ABMD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ClaytonHP < 20 3/27/2009 Outperform 3M $5.42 +4,801.85% +286.96% +4,514.89 0 Comment
NoWhereToGoButUp 65.94 3/25/2009 Outperform NS $5.44 +4,783.82% +298.47% +4,485.35 0 Comment
Dennyf10 60.20 6/3/2009 Outperform 1Y $6.44 +4,025.47% +241.38% +3,784.08 0 Comment
TSStechtrader 43.22 8/11/2009 Outperform NS $7.31 +3,534.47% +214.02% +3,320.45 0 Comment
dteasley4 88.47 6/8/2009 Outperform 3Y $7.30 +3,539.45% +238.34% +3,301.11 0 Comment
YahooSIRIous 66.24 7/13/2009 Outperform 5Y $7.93 +3,250.32% +257.53% +2,992.78 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. henrik1123 29.00 1/8/2010 Outperform 5Y $8.21 +3,134.83% +175.21% +2,959.63 0 Comment
QuickStoch 94.34 7/15/2009 Outperform 3W $8.06 +3,196.28% +240.47% +2,955.81 0 Comment
PitBullCapital < 20 1/11/2010 Outperform 5Y $8.29 +3,104.83% +173.05% +2,931.77 0 Comment
ezdoggy 61.50 12/29/2009 Outperform 5Y $8.80 +2,919.09% +178.06% +2,741.04 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ABMD.